Teva announces FDA approval, commercial launch of generic ARIMIDEX
Teva Pharmaceutical Industries Ltd. announced today U.S. Food and Drug Administration (FDA) approval and commercial launch of Anastrozole Tablets 1 mg, the Company's generic version of AstraZeneca's ARIMIDEX®.